Detectnet is a radioactive “tracer” or isotope specific to imaging somatostatin receptor positive neuroendocrine tumors (NETs) or carcinoid tumors in adult patients.
Patient prep for the exam:
Your Cancer Doctor will have you stop taking Somatostatin analog medication for the recommended duration:
- Long acting for a minimum of 28 days prior to scan
a. Octreotide LAR (Octreotide Acetate)
b. LANREOTIDE (Lanreotide acetate)
c. Pasireotide (Pasireotide Diaspartate)
- Short acting for a minimum of 2 days prior to scan
b. OCTEROTIDE (Octreotide Acetate)
The day of your exam:
1) Arrive 30 min. prior to your scheduled time to allow for registration and dosing.
2) You may take your prescription medications (exception: Somatostatin Analogs discussed with your doctor)
3) Wear comfortable clothing with minimal metal and no jewelry.
4) Please allow approximately 3 hours for your appointment. This includes a 90 min. waiting period for the medication to absorb in your body and 40 min. to complete the scan.
Please call with any questions and ask for the PET/CT Imaging Department:
Decatur (217) 876-6600
Effingham (217) 342-2066
O’Fallon (618) 416-7970
1) What are Neuroendocrine tumors (NETS)?
Neuroendocrine tumors (NETs) are a heterogeneous group of rare neoplasms that originate from neuroendocrine cells. These neoplasms occur mostly in the gastrointestinal tract, pancreas and liver, but can also occur in other tissues including lung, thymus and other uncommon sites such as cervix, heart and prostate. Most NETs strongly express somatostatin receptors (SSTRs).
RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines® – Curium Pharma